Cao Z - Search Results

1

Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma.

Zeng Z, Jiang X, Pan Z, Zhou R, Lin Z, Tang Y, Cui Y, Zhang E, Cao Z. Zeng Z, et al. Among authors: cao z. Aging (Albany NY). 2021 Oct 4;13(19):22802-22829. doi: 10.18632/aging.203574. Epub 2021 Oct 4. Aging (Albany NY). 2021. PMID: 34607313 Free PMC article.

2

Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.

Cao Z, Zeng Z, Wang B, Liu C, Liu C, Wang Z, Li S. Cao Z, et al. J Ethnopharmacol. 2021 Jan 10;264:113289. doi: 10.1016/j.jep.2020.113289. Epub 2020 Aug 23. J Ethnopharmacol. 2021. PMID: 32846191

3

Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing data.

Zeng Z, Cao Z, Tang Y. Zeng Z, et al. Among authors: cao z. Oncol Lett. 2020 Nov;20(5):231. doi: 10.3892/ol.2020.12094. Epub 2020 Sep 11. Oncol Lett. 2020. PMID: 32968453 Free PMC article.

4

Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.

Zeng Z, Cao Z, Tang Y. Zeng Z, et al. Among authors: cao z. BMC Cancer. 2020 Oct 28;20(1):1037. doi: 10.1186/s12885-020-07529-2. BMC Cancer. 2020. PMID: 33115417 Free PMC article.

5

Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data.

Zeng Z, Cao Z, Zhang E, Huang H, Tang Y. Zeng Z, et al. Among authors: cao z. Biosci Rep. 2021 Jan 29;41(1):BSR20203594. doi: 10.1042/BSR20203594. Biosci Rep. 2021. PMID: 33346796 Free PMC article.

6

Shentao Ruangan formula promotes apoptosis via the E2F2-p53 pathway in hepatocellular carcinoma.

Zeng Z, Jiang W, Kan J, Zhang D, Li R, He F, Hu Y, Li X, Zhang E, Cao Z. Zeng Z, et al. Among authors: cao z. Phytomedicine. 2023 Jan;109:154565. doi: 10.1016/j.phymed.2022.154565. Epub 2022 Nov 22. Phytomedicine. 2023. PMID: 36610125

7

The improvement of modified Si-Miao granule on hepatic insulin resistance and glycogen synthesis in type 2 diabetes mellitus involves the inhibition of TNF-α/JNK1/IRS-2 pathway: network pharmacology, molecular docking, and experimental validation.

Cao Z, Wang X, Zeng Z, Yang Z, Lin Y, Sun L, Lu Q, Fan G. Cao Z, et al. Chin Med. 2024 Sep 16;19(1):128. doi: 10.1186/s13020-024-00997-9. Chin Med. 2024. PMID: 39285464 Free PMC article.

8

Correction: The improvement of modified Si-Miao granule on hepatic insulin resistance and glycogen synthesis in type 2 diabetes mellitus involves the inhibition of TNF-α/JNK1/IRS-2 pathway: network pharmacology, molecular docking, and experimental validation.

Cao Z, Wang X, Zeng Z, Yang Z, Lin Y, Sun L, Lu Q, Fan G. Cao Z, et al. Chin Med. 2024 Oct 21;19(1):146. doi: 10.1186/s13020-024-01012-x. Chin Med. 2024. PMID: 39434127 Free PMC article. No abstract available.

9

Gut microbiota mediate the alleviation effect of Xiehuo-Guzheng granules on β cell dedifferentiation in type 2 diabetes mellitus.

Cao Z, Wang X, Liu H, Yang Z, Zeng Z. Cao Z, et al. Phytomedicine. 2024 Dec;135:156151. doi: 10.1016/j.phymed.2024.156151. Epub 2024 Oct 16. Phytomedicine. 2024. PMID: 39437686

10

Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells.

Cao ZJ, You J, Fan YM, Yang JY, Sun J, Ma X, Zhang J, Li Z, Wang X, Feng YX. Cao ZJ, et al. Sci Adv. 2025 Jan 10;11(2):eads5434. doi: 10.1126/sciadv.ads5434. Epub 2025 Jan 10. Sci Adv. 2025. PMID: 39792663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,792 results

Search Page

Filters